Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 5,619 EWTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 5,619 | n/a |
| Jan 23, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 13,690 | $5.3K |
| Jun 18, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 30,000 | n/a |
| Sep 4, 2024 | SpringWorks Therapeutics, Inc. (SWTX) | Sale | 12,300 | $493.4K |
| Jun 12, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 20,594 | n/a |
| Jun 5, 2024 | SpringWorks Therapeutics, Inc. (SWTX) | Sale | 11,772 | $463.8K |
| Jan 8, 2024 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/Award | 42,312 | n/a |
| Jun 14, 2023 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 22,123 | n/a |
| Jun 28, 2022 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 42,087 | n/a |